NCT01778270

Brief Summary

This study investigates if data about monitoring the drainage of pleural effusion can be collected by non invasive sensors (feasibility).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2011

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

January 25, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 29, 2013

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2013

Completed
Last Updated

April 16, 2015

Status Verified

April 1, 2015

Enrollment Period

1.5 years

First QC Date

January 25, 2013

Last Update Submit

April 15, 2015

Conditions

Keywords

pleural effusionpleural drainagethorax impedancerespiration parametersheart sounds analysis

Outcome Measures

Primary Outcomes (1)

  • Change of thorax impedance (Ohm)

    non invasive bioimpedance measurements to determine feasibility of body fluid loss before and after pleura drainage in 25 patients \> 18 years old; also 25 healthy controls are measured to receive standard values

    once during hospital stay at baseline time 0 before pleura drainage and after pleura drainage at time 1 hour.

Secondary Outcomes (1)

  • Change of Cardiac output ( l/min) via impedance cardiography

    once during hospital stay at baseline time 0 before pleura drainage and after pleura drainage at time 1 hour

Other Outcomes (1)

  • Change of respiratory parameter CO2 in %/ml exhaled air

    once during hospital stay at baseline time 0 before pleura drainage and after pleura drainage at time 1 hour

Study Arms (2)

non invasive sensor pleural drainage

OTHER

feasibility data will be collected with thorax impedance measurements via body bioimpedance sensor in Ohm before and after pleura drainage, via impedance cardiography stroke volume and cardiac output will be calculated and also respiratory parameters determined via capnograph as carbon dioxide (CO2) in %/ml exhaled volume before and after pleura drainage. Additionally heart sound analysis via electronic stethoscope will be compared to standard methods.

Device: Body Bioimpedance Sensor

non invasive sensor healthy control

OTHER

the same measurements as in arm 1: feasibility data will be collected with thorax impedance measurements via body bioimpedance sensor before and after pleura drainage in Ohm, via impedance cardiography stroke volume and cardiac output will be calculated and also respiratory parameters determined via capnograph as carbon dioxide (CO2) in %/ml exhaled volume once in 25 healthy controls. Additionally heart sound analysis via electronic stethoscope will be compared to standard methods.

Device: Body Bioimpedance Sensor

Interventions

non invasive sensor healthy controlnon invasive sensor pleural drainage

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with pleural effusion undergoing pleural drainage
  • male and female patients aged at least 18 years

You may not qualify if:

  • pregnancy or breast feeding
  • implanted pacemaker / Cardiac Resynchronization Therapy (CRT) / Implanted Cardioverter Defibrillator (ICD) except Medtronic Device "OptiVol".
  • patients not being able to consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Univeristy Hospital Aachen

Aachen, North Rhine Westfalia, 52074, Germany

Location

Related Publications (1)

  • Zink MD, Weyer S, Pauly K, Napp A, Dreher M, Leonhardt S, Marx N, Schauerte P, Mischke K. Feasibility of bioelectrical impedance spectroscopy measurement before and after thoracentesis. Biomed Res Int. 2015;2015:810797. doi: 10.1155/2015/810797. Epub 2015 Mar 11.

MeSH Terms

Conditions

Pleural Effusion

Condition Hierarchy (Ancestors)

Pleural DiseasesRespiratory Tract Diseases

Study Officials

  • Nikolaus Marx, MD

    Medical Clinic I, University Hospital Aachen

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 25, 2013

First Posted

January 29, 2013

Study Start

October 1, 2011

Primary Completion

April 1, 2013

Study Completion

April 1, 2013

Last Updated

April 16, 2015

Record last verified: 2015-04

Locations